During the 2016 Super Bowl, Denver Broncos cornerback Aqib Talib will don a high-tech helmet to safeguard against head injury.» Read More
Aug 31- Google Inc and French drugmaker Sanofi SA said they will partner to develop tools to improve the management and treatment of diabetes. Sanofi will work with Google's life sciences team to collect, analyze and understand information impacting diabetes, which is expected to affect 592 million by 2035, according to the International Diabetes...
The healthcare secular theme isn't new, but is still very much in force.
Jim Cramer dishes his opinion on caller favorite stocks, including this one that has become too hard for him.
Stocks are flat on the year, but those lucky names delivering secular growth have prospered.
The sudden decline in both media and biotech stocks had traders pressing the sell button. Yet one technician said he's buying the dip.
Jim Cramer saw that investors could not hide from big bad China on Tuesday, including Apple.
Carter Worth says the recent price action in Apple could spell trouble for the Nasdaq.
There is a lot of money hiding out in a few sub-groups, including banks, biotech, and Internet names like Google and Facebook.
“Mad Money” host Jim Cramer says he’s being kind with his criticism of this popular ratings and reviews company.
Jim Cramer thinks leadership is lacking, which prompted the market to get crushed Friday.
Dollar strength, weak oil weigh on earnings.
U.S. stocks closed about 1 percent lower, despite surprisingly strong Amazon earnings, as signs of slower global growth weighed on sentiment.
Biogen shares sank after it lowered its 2015 forecast on slower-than-anticipated growth of its multiple sclerosis blockbuster Tecfidera.
CNBC's Meg Tirrell reports on Biogen's sales growth as the company misses sales estimates.
Jim Cramer explains why he is watching shares of Biogen after the company lowered its guidance
U.S. stock futures pointed to a slight rebound following a stronger-than-expected earnings report from online retailer Amazon.
Some of the names on the move ahead of the open.
U.S. stock futures pointed to a rebound for Wall Street shares Friday, following a stronger-than-expected earnings report from online retailer Amazon.
Stocks could get a boost Friday from Amazon's strong earnings report, which comes as some key companies are clearly stumbling over the already lowered bar for earnings.
Biogen's Alzheimer's drug showed promise in its latest study, Chief Medical Officer Alfred Sandrock said.